Defense Federal Acquisition Regulation Supplement
Healthcare and life sciences contractors selling to the Department of Defense operate under a distinct compliance layer that most sector-focused programs underestimate: the Defense Federal Acquisition Regulation Supplement, administered by the U.S. Department of Defense and enforced through oversight by the Defense Contract Audit Agency and the Defense Contract Management Agency. DFARS clauses governing cybersecurity (252.204-7012), counterfeit part controls, and cost accounting touch everything from medical device supply chains to pharma R&D contracts with military health programs. Compliance teams at defense-adjacent health companies are currently mapping their subcontractor flow-downs against CMMC 2.0 implementation timelines before DoD's phased contract insertion deadlines take effect.
Watch
- DFARS 252.204-7012 flow-down obligations for healthcare subcontractors handling CUI
- CMMC 2.0 Level 2 certification deadlines as DoD phases requirements into new contracts
- Defense Contract Audit Agency scrutiny of IR&D cost allocations in health-sector prime contracts
- Counterfeit electronic part controls under DFARS 252.246-7003 applied to medical device suppliers
- DoD class deviations affecting DFARS clauses in active healthcare and biodefense solicitations
Recent material activity in Healthcare & Life Sciences
Active monitoring in place across Healthcare & Life Sciences. Material developments related to defense federal acquisition regulation supplement will appear here as they are published.